Industrials
UV Flu Technologies, Inc.(UVFT)
Live Price
Offline$0.0002
+0.00% today
1Y Change
+100.00%
Window
Jun 20, 2025 → Jun 15, 2026
- Market Cap
- —
- Revenue Growth
- +54.3%
- EPS Growth
- +18.9%
- Dividend Yield
- 0.0%
Coverage: 250 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
UV Flu Technologies, Inc. (UVFT) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +54.3%, EPS growth of +18.9%, a dividend yield of 0.0%. What stands out right now is revenue +54.3%, EPS +18.9%, free cash flow +11.3% with operating margin -529.8% and ROIC 252.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines UVFT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+54.3% vs +3.6% peer median
Operating Margin
Below sector median
-529.8% vs +16.9% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +54.3% and EPS at +18.9%, with operating margin around -529.8%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UVFT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UVFT Max Drawdown
-66.67%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for UVFT and SPY.
Company Overview
UV Flu Technologies, Inc.
Other OTC
UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers. Its products are used in hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casinos, and military installations. The company was formerly known as Northwest Chariots Incorporated and changed its name to UV Flu Technologies, Inc. in November 2009. UV Flu Technologies, Inc. was founded in 2006 and is based in Lincolnshire, Illinois.
- Leadership
- Michael S. Ross
- IPO Date
- Nov 24, 2009
- Employees
- 1
- Street Address
- 250 Parkway Drive
- Mailing
- Lincolnshire, IL, 60069
- Region
- Lincolnshire, IL, US
- Reporting Currency
- USD
- Investor Line
- 877-358-5455
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.2
- Price/Book
- —
Growth
- Revenue
- +54.3%
- EPS
- +18.9%
- Free Cash Flow
- +11.3%
Profitability
- Gross Margin
- 11.3%
- Operating Margin
- -529.8%
- Net Margin
- -539.4%
- ROE
- 137.8%
- ROIC
- 252.2%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.16
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.